Stribild is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Gilead Sciences, Inc.. The primary component is Elvitegravir; Cobicistat; Emtricitabine; Tenofovir Disoproxil Fumarate.
| Product ID | 61958-1201_8c36d9fb-28e9-4d73-851b-968d9752a3d4 | 
| NDC | 61958-1201 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Stribild | 
| Generic Name | Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate | 
| Dosage Form | Tablet, Film Coated | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2012-08-27 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA203100 | 
| Labeler Name | Gilead Sciences, Inc. | 
| Substance Name | ELVITEGRAVIR; COBICISTAT; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE | 
| Active Ingredient Strength | 150 mg/1; mg/1; mg/1; mg/1 | 
| Pharm Classes | HIV Integrase Inhibitors [MoA],Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 3A Inhibitor [EPC],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleosides [CS],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleosides [CS],Nucleoside Reverse Transcriptase Inhibitors [MoA] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2022-12-31 | 
| Marketing Start Date | 2012-08-27 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA203100 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2012-08-27 | 
| Ingredient | Strength | 
|---|---|
| ELVITEGRAVIR | 150 mg/1 | 
| SPL SET ID: | 74ae2a93-b267-444c-8f0f-a2a6522260ee | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 50090-1318 | Stribild | elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate | 
| 53808-0887 | Stribild | elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate | 
| 61958-1201 | Stribild | elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate | 
| 69189-1201 | Stribild | elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate | 
| 70518-0674 | Stribild | elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  STRIBILD  85688699  4320307 Live/Registered | GILEAD SCIENCES IRELAND UC 2012-07-27 | 
|  STRIBILD  85555217  4263613 Live/Registered | GILEAD SCIENCES IRELAND UC 2012-02-28 |